| 발행주식수 | 9,930,329 shares |
| 내부자 지분 | 1,198,185 shares |
| 내부자 주주 | 12.07 % |
| 전체 내부자 | 37 |
내부자 센티멘트 점수
내부자 센티멘트 점수를 통해서 내부자들이 법인 지분을 매입하는 기업들에 대해서 알아볼 수 있습니다.
이는 내부자의 누적도가 가장 높은 기업을 식별하는 정교하고 복합적인 지수를 분석하는 계량 모델의 결과 값입니다. 스코어링 모델은 이전 90일 동안 매수한 "내부자의 순 숫자", "매수한 주식의 총합", "내부자가 소유한 주식의 총합"의 조합을 사용합니다. 점수는 0에서 100 사이이며, 점수가 높을수록 피어(Peer: 동종업계 경쟁기업)에 대한 누적도가 높다는 것을 나타내며, 평균은 50입니다.
업데이트 주기: 일별
내부자의 누적도가 가장 높은 기업 목록을 확인할 수 있는 내부자들의 최다 선택(Insiders Top Picks)을 참고하십시오.
내부 경영진 센티멘트 점수
내부 경영진 센티멘트 점수를 통해서 내부 경영진들이 법인 지분을 매입하는 기업들에 대해서 알아볼 수 있습니다.
내부 거래의 정의에 따라 내부 경영진(기업 임원)도 내부자이지만, 다른 내부자(10% 주주 및 이사회 구성원)들과는 달리 내부 경영진은 매일 회사에서 근무하며, 거래 시에 자신의 자금을 사용합니다. (많은 경우에 10% 주주 및 이사회 구성원은 다른 사람의 자금을 관리하는 자금 관리자입니다.) 따라서 내부 경영진(기업 임원: Officer)의 내부 거래는 훨씬 더 중요하며 올바른 분석이 필요합니다.
내부자 센티멘트 점수와 마찬가지로 임원 감정 점수는 가장 높은 수준의 임원 축적을 가진 기업을 식별하는 정교하고 복합적인 지수 퀀트(Multi-factor quantitative) 모델의 결과입니다.
업데이트 주기: 일별
내부자의 누적도가 가장 높은 기업 목록을 확인할 수 있는 내부자들의 최다 선택(Insiders Top Picks)을 참고하십시오.
주요 내부자 지표
이 수치는 해당 기업이 다양한 내부자 지표에 따라 어떻게 순위를 매겨지는 지를 설명합니다. 백분위 순위는 이 기업이 미국 시장의 다른 기업들과 어떻게 비교되는지 보여줍니다. 순위가 높을수록 더 나은 상황에 있다는 것을 의미합니다.
예를 들어, 일반적으로 내부자의 매입은 긍정적인 지표라고 간주되어지기 때문에, 내부자의 매입(내부자의 매각, 역시도)가 적은 기업보다 내부자의 매입이 많은 기업은 순위가 높을 것입니다.
내부자 트레이딩 차트
SCYNEXIS, Inc. 내부자의 매매 거래는 아래 차트에 나와 있습니다. 내부자들은 기업의 임원(내부 경영진), 이사 또는 주요 투자자입니다. 일반적으로 내부자가 중요한 비공개 정보를 기반으로 자신이 속한 기업을 거래하는 것은 불법으로 간주됩니다. 이것은 내부자가 자신의 기업 내에서 행하는 모든 거래가 불법이라는 것을 뜻은 아닙니다. 그러나 그들은 자신들의 모든 거래를 양식 4를 통해 SEC에 보고해야만 합니다.
내부자의 명단 및 이익 지표
아래 표는 공개된 내부자의 목록이며, SEC에 공개된 제출 문서에서 자동으로 생성됩니다. "이름", "가장 최근의 직급", "이사, 임원 또는 10% 주주"에 대한 지정 외에도 최근에 공개된 보유 주식에 대한 정보를 보여줍니다. 또한 가능한 경우 내부자의 과거 거래 실적도 확인 가능합니다. 과거 거래 실적은 내부자가 실제 "공개 시장"(Open market) 매입 거래를 수행한 실적을 가중 평균한 값입니다. 이 계산 방법에 대한 자세한 내용은 유튜브 웨비나 를 참조하시면 됩니다.
See our leaderboard of most profitable insider traders.
| 내부자 | 평균 이익률 (%) | 소유 지분 |
주식 분할 |
|---|---|---|---|
|
Alta Biopharma Management Ii Llc
10% Owner -
|
45,736 | 5,082 | |
|
Alta Biopharma Partners Ii Lp
10% Owner -
|
45,736 | 5,082 | |
|
Alta Embarcadero Biopharma Partners Ii Llc
10% Owner -
|
45,736 | 5,082 | |
| Armando Anido Director - [D] | 71,000 | 8,875 | |
| Gonzalez David Angulo Chief Executive Officer, Director - [D] [O] | 1,357,126 | 169,641 | |
| Laurent Arthaud Director - [D] | 4,507 | 501 | |
|
Farah Champsi
10% Owner -
|
45,736 | 5,082 | |
| Mounia Chaoui | 3,480 | ||
| Christine Coyne Chief Commercial Officer - [O] | 58,200 | 7,275 | |
|
Joseph Edelman
10% Owner -
|
2,400,000 | 300,000 | |
|
F.C.P.R. Genavent
10% Owner -
|
237,598 | 26,400 | |
|
FCPR Biotechnology Fund
10% Owner -
|
295,077 | 32,786 |
| 내부자 | 평균 이익률 (%) | 소유 지분 |
주식 분할 |
|---|---|---|---|
| Eric Francois Chief Financial Officer - [O] | 11,732 | 1,466 | |
| Steven C Gilman Director - [D] | 70,000 | 8,750 | |
| Michael C Garrett Vice President - [O] | 6,216 | 691 | |
| Ann Hanham Director - [D] | 69,622 | 8,703 | |
| David C Hastings Director - [D] | 69,183 | 8,648 | |
| Pamela J Kirby Director - [D] | 25,590 | 2,843 | |
| Patrick Langlois Director - [D] | 10,503 | 1,167 | |
| Guy Macdonald Director - [D] | 78,000 | 9,750 | |
| Patrick Machado Director - [D] | 60,000 | 6,667 | |
| ivor Macleod Chief Financial Officer - [O] | 398,529 | 49,816 | |
| Marion McCourt | 9,217 | ||
| Jean-Yves Nothias Director - [D] | 295,077 | 32,786 |
| 내부자 | 평균 이익률 (%) | 소유 지분 |
주식 분할 |
|---|---|---|---|
| Osborne, Jr. Charles F Chief Financial Officer - [O] | 17,900 | 1,989 | |
| Edward Penhoet | 8,800 | ||
|
Perceptive Advisors Llc
10% Owner -
|
2,400,000 | 300,000 | |
|
Perceptive Life Sciences Master Fund Ltd
10% Owner -
|
1,800,000 | 300,000 | |
| Eileen Pruette | 25,230 | ||
| Yves J Ribeill President and CEO, Director - [D] [O] | 1,190 | 132 | |
| Carole Sable | 26,970 | ||
|
Sanofi
10% Owner -
|
3,177,057 | 353,006 | |
| Scott Sukenick Chief Legal Officer - [O] | 574,539 | 71,817 | |
| Marco Taglietti Chief Executive Officer, Director - [D] [O] | 272,068 | 34,008 | |
| Brian Philippe Tinmouth Director - [D] | 74,000 | 9,250 | |
|
Capital II Ventech
10% Owner -
|
414,211 | 46,023 | |
| Jonathan Sears Woodall Interim Chief FinancialOfficer - [O] | 1,000 | 111 |
Report errors via our new Insider Auditing Tool
내부자의 매입 내역 추적: 단기 이익 분석
이 섹션에서는 SCYX / SCYNEXIS, Inc.에서 계획되지 않은 "공개 시장"(Open market)의 내부자가 매입한 모든 상품의 수익성을 분석합니다. 이 분석을 통해서 내부자가 비정상적인 수익을 지속적으로 창출하는지 파악하는 데 도움이 되며, 이러한 분석은 수행해볼 가치가 있습니다. 이 분석은 개별 거래 후 1년 동안 수행한 것이며, 결과는 이론 값입니다. .
아래 표는 사전 거래 계획(Automated trading plan)에 포함되지 않은 가장 최근의 "공개 시장"(Open market)에서의 매입을 보여줍니다.
조정된 가격은 분할 조정 가격입니다. 조정된 지분은 분할 조정 지분입니다.
내부자 매매의 실적: 단기 손실 분석
이 섹선에서는 SCYX / SCYNEXIS, Inc.에서 이루어진 "공개 시장(Open market)"에서의 모든 계획되지 않은 내부자 매매의 단기 손실 회피(Short-term loss avoidance)를 분석합니다. 일관된 손실 회피 패턴을 통해서 향후 매매 거래가 가격 하락을 초래할 수도 있음을 예상할 수 있습니다. 이 분석은 각 각 매매 거래 후 1년 동안의 자료이며, 결과는 이론 값입니다. .
아래 표는 사전 거래 계획(Automated trading plan)에 포함되지 않은 가장 최근의 공개 시장에서의 매매를 보여줍니다.
조정된 가격은 분할 조정 가격입니다. 조정된 지분은 분할 조정 지분입니다.
거래 내역
전체 거래 내역을 보려면 링크 아이콘을 클릭하세요. 10b5-1 자동 거래 계획의 일부로 보고된 거래는 10b-5 열에 X 표시가 나타납니다.
| 보고일 | 거래일 | 양식 | 내부자 | 티커 | 증권 소유권 | 코드 | 직접 | 행사 가격 |
단위 가격 |
단위 변동 |
가치 변동 (단위: 1,000) |
잔여 옵션 |
잔여 주식 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-02 | 2026-04-01 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 108,695 | 1,357,126 | ||||||
| 2026-02-02 | 2026-01-29 | 4 | Macleod ivor | SCYX | Common Stock | D | 129,833 | 398,529 | ||||||
| 2026-02-02 | 2026-01-29 | 4 | Sukenick Scott | SCYX | Common Stock | D | 129,833 | 574,539 | ||||||
| 2026-02-02 | 2026-01-29 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 391,333 | 1,244,431 | ||||||
| 2025-10-21 | 2025-10-17 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 0.7600 | 32,500 | 25 | 853,098 | ||||
| 2025-06-30 | 2025-06-26 | 4 | Tinmouth Brian Philippe | SCYX | Common Stock | D | 23,000 | 74,000 | ||||||
| 2025-06-30 | 2025-06-26 | 4 | Macdonald Guy | SCYX | Common Stock | D | 23,000 | 78,000 | ||||||
| 2025-06-30 | 2025-06-26 | 4 | HASTINGS DAVID C | SCYX | Common Stock | D | 23,000 | 69,183 | ||||||
| 2025-06-30 | 2025-06-26 | 4 | HANHAM ANN | SCYX | Common Stock | D | 23,000 | 69,622 | ||||||
| 2025-06-30 | 2025-06-26 | 4 | GILMAN STEVEN C | SCYX | Common stock | D | 23,000 | 70,000 | ||||||
| 2025-06-30 | 2025-06-26 | 4 | ANIDO ARMANDO | SCYX | Common Stock | D | 23,000 | 71,000 | ||||||
| 2025-04-10 | 2025-04-09 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 0.8400 | 23,000 | 19 | 816,598 | ||||
| 2025-03-20 | 2025-03-20 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1.0500 | 13,800 | 14 | 793,598 | ||||
| 2025-03-20 | 2025-03-19 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1.0700 | 5,000 | 5 | 779,798 | ||||
| 2025-01-27 | 2025-01-23 | 4 | Sukenick Scott | SCYX | Common Stock | D | 92,511 | 436,706 | ||||||
| 2025-01-27 | 2025-01-23 | 4 | Macleod ivor | SCYX | Common Stock | D | 92,511 | 260,696 | ||||||
| 2025-01-27 | 2025-01-23 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 262,927 | 770,798 | ||||||
| 2024-09-16 | 2024-09-12 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1.3700 | 20,000 | 27 | 507,871 | ||||
| 2024-06-21 | 2024-06-20 | 4 | Macdonald Guy | SCYX | Common Stock | D | 23,000 | 55,000 | ||||||
| 2024-06-21 | 2024-06-20 | 4 | HASTINGS DAVID C | SCYX | Common Stock | D | 23,000 | 46,183 | ||||||
| 2024-06-21 | 2024-06-20 | 4 | GILMAN STEVEN C | SCYX | Common Stock | D | 23,000 | 47,000 | ||||||
| 2024-06-21 | 2024-06-20 | 4 | Tinmouth Brian Philippe | SCYX | Common Stock | D | 23,000 | 51,000 | ||||||
| 2024-06-21 | 2024-06-20 | 4 | ANIDO ARMANDO | SCYX | Common Stock | D | 23,000 | 48,000 | ||||||
| 2024-06-21 | 2024-06-20 | 4 | HANHAM ANN | SCYX | Common Stock | D | 23,000 | 46,622 | ||||||
| 2024-02-16 | 2024-02-16 | 4 | Sukenick Scott | SCYX | Common Stock | D | 1.6300 | -15,179 | -25 | 336,195 | ||||
| 2024-01-30 | 2024-01-26 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 290,590 | 479,871 | ||||||
| 2024-01-30 | 2024-01-26 | 4 | Macleod ivor | SCYX | Common Stock | D | 143,675 | 160,185 | ||||||
| 2024-01-30 | 2024-01-26 | 4 | Sukenick Scott | SCYX | Common Stock | D | 143,675 | 351,374 | ||||||
| 2023-06-23 | 2023-06-15 | 4 | HASTINGS DAVID C | SCYX | Common Stock | D | 10,000 | 23,183 | ||||||
| 2023-06-23 | 2023-06-15 | 4 | HANHAM ANN | SCYX | Common Stock | D | 10,000 | 23,622 | ||||||
| 2023-06-23 | 2023-06-15 | 4 | GILMAN STEVEN C | SCYX | Common Stock | D | 10,000 | 24,000 | ||||||
| 2023-06-23 | 2023-06-15 | 4 | ANIDO ARMANDO | SCYX | Common Stock | D | 10,000 | 25,000 | ||||||
| 2023-06-23 | 2023-06-15 | 4 | Tinmouth Brian Philippe | SCYX | Common Stock | D | 10,000 | 28,000 | ||||||
| 2023-06-23 | 2023-06-15 | 4 | Macdonald Guy | SCYX | Common Stock | D | 10,000 | 32,000 | ||||||
| 2023-05-17 | 2023-05-15 | 4 | Sukenick Scott | SCYX | Common Stock | D | 50,000 | 203,599 | ||||||
| 2023-01-31 | 2023-01-27 | 4 | Sukenick Scott | SCYX | Common Stock | D | 100,000 | 153,599 | ||||||
| 2023-01-03 | 2023-01-01 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 110,000 | 185,181 | ||||||
| 2022-10-26 | 2022-10-24 | 4 | Macleod ivor | SCYX | Common Stock | D | 15,000 | 15,000 | ||||||
| 2022-06-22 | 2022-06-17 | 4 | Tinmouth Brian Philippe | SCYX | Common Stock | D | 10,000 | 18,000 | ||||||
| 2022-06-22 | 2022-06-17 | 4 | Macdonald Guy | SCYX | Common Stock | D | 10,000 | 22,000 | ||||||
| 2022-06-22 | 2022-06-17 | 4 | HASTINGS DAVID C | SCYX | Common Stock | D | 10,000 | 13,183 | ||||||
| 2022-06-22 | 2022-06-17 | 4 | HANHAM ANN | SCYX | Common Stock | D | 10,000 | 13,622 | ||||||
| 2022-06-22 | 2022-06-17 | 4 | GILMAN STEVEN C | SCYX | Common Stock | D | 10,000 | 14,000 | ||||||
| 2022-06-22 | 2022-06-17 | 4 | ANIDO ARMANDO | SCYX | Common Stock | D | 10,000 | 15,000 | ||||||
| 2022-04-28 | 2022-04-26 | 4 | Taglietti Marco | SCYX | Common Stock Warrant | D | 3.45 | 75,000 | 75,000 | |||||
| 2022-04-28 | 2022-04-26 | 4 | Taglietti Marco | SCYX | Common Stock | D | 3.0000 | 75,000 | 225 | 272,068 | ||||
| 2022-04-28 | 2022-04-26 | 4 | Sukenick Scott | SCYX | Common Stock Warrant | D | 3.45 | 3,500 | 3,500 | |||||
| 2022-04-28 | 2022-04-26 | 4 | Sukenick Scott | SCYX | Common Stock | D | 3.0000 | 3,500 | 10 | 53,499 | ||||
| 2022-02-08 | 2022-02-04 | 4 | Coyne Christine | SCYX | Stock Option (Right to Buy) | D | 4.60 | 75,000 | 75,000 | |||||
| 2022-02-08 | 2022-02-04 | 4 | Coyne Christine | SCYX | Common Stock | D | 43,200 | 58,200 | ||||||
| 2022-02-08 | 2022-02-04 | 4 | Sukenick Scott | SCYX | Stock Option (Right to Buy) | D | 4.60 | 70,000 | 70,000 | |||||
| 2022-02-08 | 2022-02-04 | 4 | Sukenick Scott | SCYX | Common Stock | D | 40,700 | 49,899 | ||||||
| 2022-02-08 | 2022-02-04 | 4 | Angulo Gonzalez David | SCYX | Stock Option (Right to Buy) | D | 4.60 | 85,000 | 85,000 | |||||
| 2022-02-08 | 2022-02-04 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 51,100 | 74,981 | ||||||
| 2022-02-08 | 2022-02-04 | 4 | Taglietti Marco | SCYX | Stock Option (Right to Buy) | D | 4.60 | 232,000 | 232,000 | |||||
| 2022-02-08 | 2022-02-04 | 4 | Taglietti Marco | SCYX | Common Stock | D | 87,200 | 196,968 | ||||||
| 2021-06-21 | 2021-06-16 | 4 | Macdonald Guy | SCYX | Stock Option (Right to Buy) | D | 7.51 | 10,000 | 10,000 | |||||
| 2021-06-21 | 2021-06-16 | 4 | Tinmouth Brian Philippe | SCYX | Stock Option (Right to Buy) | D | 7.51 | 10,000 | 10,000 | |||||
| 2021-06-21 | 2021-06-16 | 4 | HASTINGS DAVID C | SCYX | Stock Option (Right to Buy) | D | 7.51 | 10,000 | 10,000 | |||||
| 2021-06-21 | 2021-06-16 | 4 | GILMAN STEVEN C | SCYX | Stock Option (Right to Buy) | D | 7.51 | 10,000 | 10,000 | |||||
| 2021-06-21 | 2021-06-16 | 4 | HANHAM ANN | SCYX | Stock Option (Right to Buy) | D | 7.51 | 10,000 | 10,000 | |||||
| 2021-06-21 | 2021-06-16 | 4 | ANIDO ARMANDO | SCYX | Stock Option (Right to Buy) | D | 7.51 | 10,000 | 10,000 | |||||
| 2021-05-12 | 2021-05-10 | 4 | Coyne Christine | SCYX | Stock Option (Right to Buy) | D | 6.50 | 125,000 | 125,000 | |||||
| 2021-05-12 | 2021-05-10 | 4 | Coyne Christine | SCYX | Common Stock | D | 15,000 | 15,000 | ||||||
| 2021-03-31 | 2020-07-06 | 4/A | HASTINGS DAVID C | SCYX | Stock Option (Right to Buy) | D | 0.73 | 55,000 | 55,000 | |||||
| 2021-03-31 | 2020-07-06 | 4/A | Macdonald Guy | SCYX | Stock Option (Right to Buy) | D | 0.73 | 55,000 | 55,000 | |||||
| 2021-03-31 | 2020-07-06 | 4/A | Tinmouth Brian Philippe | SCYX | Stock Option (Right to Buy) | D | 0.73 | 55,000 | 55,000 | |||||
| 2021-03-31 | 2020-07-06 | 4/A | GILMAN STEVEN C | SCYX | Stock Option (Right to Buy) | D | 0.73 | 55,000 | 55,000 | |||||
| 2021-03-31 | 2020-07-06 | 4/A | HANHAM ANN | SCYX | Stock Option (Right to Buy) | D | 0.73 | 55,000 | 55,000 | |||||
| 2021-03-31 | 2020-07-06 | 4/A | ANIDO ARMANDO | SCYX | Stock Option (Right to Buy) | D | 0.73 | 55,000 | 55,000 | |||||
| 2021-02-02 | 2021-01-29 | 4 | Taglietti Marco | SCYX | Stock Option (Right to Buy) | D | 7.47 | 170,000 | 170,000 | |||||
| 2021-02-02 | 2021-01-29 | 4 | Sukenick Scott | SCYX | Stock Option (Right to Buy) | D | 7.47 | 40,000 | 40,000 | |||||
| 2021-02-02 | 2021-01-29 | 4 | Francois Eric | SCYX | Stock Option (Right to Buy) | D | 7.47 | 65,000 | 65,000 | |||||
| 2021-02-02 | 2021-01-29 | 4 | Angulo Gonzalez David | SCYX | Stock Option (Right to Buy) | D | 7.47 | 65,000 | 65,000 | |||||
| 2021-01-26 | 2021-01-22 | 4 | PERCEPTIVE ADVISORS LLC | SCYX | Common Stock | I | 8.9500 | -33,849 | -303 | 1,800,000 | ||||
| 2021-01-26 | 2021-01-22 | 4 | PERCEPTIVE ADVISORS LLC | SCYX | Common Stock | I | 8.1600 | -285,151 | -2,327 | 1,833,849 | ||||
| 2021-01-26 | 2021-01-21 | 4 | PERCEPTIVE ADVISORS LLC | SCYX | Common Stock | I | 7.3800 | -95,000 | -701 | 2,120,000 | ||||
| 2021-01-26 | 2021-01-20 | 4 | PERCEPTIVE ADVISORS LLC | SCYX | Common Stock | I | 7.4300 | -185,000 | -1,375 | 2,215,000 | ||||
| 2021-01-26 | 3 | EDELMAN JOSEPH | SCYX | Common Stock | I | 2,400,000 | ||||||||
| 2020-12-23 | 2020-12-21 | 4 | Tinmouth Brian Philippe | SCYX | Common Stock Warrant | D | 7.33 | 4,000 | 4,000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Tinmouth Brian Philippe | SCYX | Common Stock Warrant | D | 8.25 | 4,000 | 4,000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Tinmouth Brian Philippe | SCYX | Common Stock | D | 6.2500 | 8,000 | 50 | 8,000 | ||||
| 2020-12-23 | 2020-12-21 | 4 | Sukenick Scott | SCYX | Common Stock Warrant | D | 8.25 | 800 | 800 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Sukenick Scott | SCYX | Common Stock Warrant | D | 7.33 | 800 | 800 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Sukenick Scott | SCYX | Common Stock | D | 6.2500 | 1,600 | 10 | 9,099 | ||||
| 2020-12-23 | 2020-12-21 | 4 | Taglietti Marco | SCYX | Common Stock Warrant | D | 8.25 | 20,000 | 20,000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Taglietti Marco | SCYX | Common Stock Warrant | D | 7.33 | 20,000 | 20,000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Taglietti Marco | SCYX | Common Stock | D | 6.2500 | 40,000 | 250 | 109,668 | ||||
| 2020-12-23 | 2020-12-21 | 4 | Macdonald Guy | SCYX | Common Stock Warrant | D | 8.25 | 4,000 | 4,000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Macdonald Guy | SCYX | Common Stock Warrant | D | 7.33 | 4,000 | 4,000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Macdonald Guy | SCYX | Common Stock | D | 6.2500 | 8,000 | 50 | 12,000 | ||||
| 2020-12-23 | 2020-12-21 | 4 | HANHAM ANN | SCYX | Common Stock Warrant | D | 8.25 | 1,600 | 1,600 | |||||
| 2020-12-23 | 2020-12-21 | 4 | HANHAM ANN | SCYX | Common Stock Warrant | D | 7.33 | 1,600 | 1,600 | |||||
| 2020-12-23 | 2020-12-21 | 4 | HANHAM ANN | SCYX | Common Stock | D | 6.2500 | 3,200 | 20 | 3,622 | ||||
| 2020-12-23 | 2020-12-21 | 4 | GILMAN STEVEN C | SCYX | Common Stock Warrant | D | 8.25 | 2,000 | 2,000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | GILMAN STEVEN C | SCYX | Common Stock Warrant | D | 7.33 | 2,000 | 2,000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | GILMAN STEVEN C | SCYX | Common Stock | D | 6.2500 | 4,000 | 25 | 4,000 | ||||
| 2020-12-23 | 2020-12-21 | 4 | Francois Eric | SCYX | Common Stock Warrant | D | 8.25 | 300 | 300 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Francois Eric | SCYX | Common Stock Warrant | D | 7.33 | 300 | 300 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Francois Eric | SCYX | Common Stock | D | 6.2500 | 600 | 4 | 11,732 | ||||
| 2020-12-23 | 2020-12-21 | 4 | ANIDO ARMANDO | SCYX | Common Stock Warrant | D | 7.33 | 2,500 | 2,500 | |||||
| 2020-12-23 | 2020-12-21 | 4 | ANIDO ARMANDO | SCYX | Common Stock Warrant | D | 8.25 | 2,500 | 2,500 | |||||
| 2020-12-23 | 2020-12-21 | 4 | ANIDO ARMANDO | SCYX | Common Stock | D | 6.2500 | 5,000 | 31 | 5,000 | ||||
| 2020-12-23 | 2020-12-21 | 4 | Angulo Gonzalez David | SCYX | Common Stock Warrant | D | 7.33 | 800 | 800 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Angulo Gonzalez David | SCYX | Common Stock Warrant | D | 8.25 | 800 | 800 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 6.2500 | 1,600 | 10 | 23,780 | ||||
| 2020-12-04 | 2020-11-25 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 6.8100 | -4,323 | -29 | 22,180 | ||||
| 2020-12-04 | 2020-02-15 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 9.8000 | -1,175 | -12 | 26,303 | ||||
| 2020-12-04 | 2020-11-25 | 4 | Francois Eric | SCYX | Common Stock | D | 6.8100 | -3,480 | -24 | 11,132 | ||||
| 2020-12-04 | 2020-02-15 | 4 | Francois Eric | SCYX | Common Stock | D | 9.8000 | -979 | -10 | 14,412 | ||||
| 2020-12-04 | 2020-11-25 | 4 | Sukenick Scott | SCYX | Common Stock | D | 6.8100 | -2,613 | -18 | 7,499 | ||||
| 2020-12-04 | 2020-02-15 | 4 | Sukenick Scott | SCYX | Common Stock | D | 9.8000 | -783 | -8 | 9,912 | ||||
| 2020-07-08 | 2020-07-06 | 4 | HANHAM ANN | SCYX | Stock Option (Right to Buy) | D | 0.73 | 45,000 | 45,000 | |||||
| 2020-07-08 | 2020-07-06 | 4 | Macdonald Guy | SCYX | Stock Option (Right to Buy) | D | 0.73 | 45,000 | 45,000 | |||||
| 2020-07-08 | 2020-07-06 | 4 | Tinmouth Brian Philippe | SCYX | Stock Option (Right to Buy) | D | 0.73 | 45,000 | 45,000 | |||||
| 2020-07-08 | 2020-07-06 | 4 | HASTINGS DAVID C | SCYX | Stock Option (Right to Buy) | D | 0.73 | 45,000 | 45,000 | |||||
| 2020-07-08 | 2020-07-06 | 4 | ANIDO ARMANDO | SCYX | Stock Option (Right to Buy) | D | 0.73 | 45,000 | 45,000 | |||||
| 2020-07-08 | 2020-07-06 | 4 | GILMAN STEVEN C | SCYX | Stock Option (Right to Buy) | D | 0.73 | 45,000 | 45,000 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Taglietti Marco | SCYX | Stock Option (Right to Buy) | D | 0.86 | 900,000 | 900,000 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Angulo Gonzalez David | SCYX | Stock Option (Right to Buy) | D | 0.86 | 450,000 | 450,000 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Francois Eric | SCYX | Stock Option (Right to Buy) | D | 0.86 | 375,000 | 375,000 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Sukenick Scott | SCYX | Stock Option (Right to Buy) | D | 0.86 | 250,000 | 250,000 | |||||
| 2019-12-17 | 2019-12-13 | 4 | Tinmouth Brian Philippe | SCYX | Stock Option (right to buy) | D | 0.73 | 70,000 | 70,000 | |||||
| 2019-12-16 | 2019-12-12 | 4 | Taglietti Marco | SCYX | Common Stock Warrant (right to buy) | D | 1.10 | 166,667 | 166,667 | |||||
| 2019-12-16 | 2019-12-12 | 4 | Taglietti Marco | SCYX | Common Stock | D | 0.9000 | 166,667 | 150 | 693,682 | ||||
| 2019-08-22 | 2019-08-21 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1.1100 | 9,500 | 11 | 526,015 | ||||
| 2019-08-22 | 2019-08-20 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1.1100 | 500 | 1 | 516,515 | ||||
| 2019-08-19 | 2019-08-15 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1.0100 | 10,015 | 10 | 516,015 | ||||
| 2019-06-20 | 2019-06-18 | 4 | HANHAM ANN | SCYX | Stock Option (Right to Buy) | D | 1.29 | 45,000 | 45,000 | |||||
| 2019-06-20 | 2019-06-18 | 4 | HASTINGS DAVID C | SCYX | Stock Option (Right to Buy) | D | 1.29 | 45,000 | 45,000 | |||||
| 2019-06-20 | 2019-06-18 | 4 | Macdonald Guy | SCYX | Stock Option (Right to Buy) | D | 1.29 | 45,000 | 45,000 | |||||
| 2019-06-20 | 2019-06-18 | 4 | ANIDO ARMANDO | SCYX | Stock Option (Right to Buy) | D | 1.29 | 45,000 | 45,000 | |||||
| 2019-06-20 | 2019-06-18 | 4 | GILMAN STEVEN C | SCYX | Stock Option (Right to Buy) | D | 1.29 | 45,000 | 45,000 | |||||
| 2019-04-18 | 2019-04-17 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1.6300 | 25,000 | 41 | 506,000 | ||||
| 2019-02-19 | 2019-02-15 | 4 | Angulo Gonzalez David | SCYX | Stock Option (Right to Buy) | D | 1.38 | 150,000 | 150,000 | |||||
| 2019-02-19 | 2019-02-15 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 150,000 | 271,790 | ||||||
| 2019-02-19 | 2019-02-15 | 4 | Francois Eric | SCYX | Stock Option (Right to Buy) | D | 1.38 | 125,000 | 125,000 | |||||
| 2019-02-19 | 2019-02-15 | 4 | Francois Eric | SCYX | Common Stock | D | 125,000 | 149,917 | ||||||
| 2019-02-19 | 2019-02-15 | 4 | Sukenick Scott | SCYX | Stock Option (Right to Buy) | D | 1.38 | 100,000 | 100,000 | |||||
| 2019-02-19 | 2019-02-15 | 4 | Sukenick Scott | SCYX | Common Stock | D | 100,000 | 102,959 | ||||||
| 2019-02-19 | 2019-02-15 | 4 | Taglietti Marco | SCYX | Stock Option (Right to Buy) | D | 1.38 | 700,000 | 700,000 | |||||
| 2019-01-23 | 2019-01-21 | 4 | ANIDO ARMANDO | SCYX | Stock Option (right to buy) | D | 0.74 | 70,000 | 70,000 | |||||
| 2019-01-14 | 2019-01-10 | 4 | Taglietti Marco | SCYX | Common Stock | D | 0.6900 | 25,000 | 17 | 480,000 | ||||
| 2019-01-04 | 2019-01-02 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 0.54 | 22,500 | 22,500 | |||||
| 2019-01-04 | 2019-01-02 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 0.54 | 22,500 | 22,500 | |||||
| 2019-01-04 | 2019-01-02 | 4 | HASTINGS DAVID C | SCYX | Stock Option (right to buy) | D | 0.54 | 22,500 | 22,500 | |||||
| 2019-01-04 | 2019-01-02 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 0.54 | 22,500 | 22,500 | |||||
| 2019-01-04 | 2019-01-02 | 4 | Machado Patrick | SCYX | Stock Option (right to buy) | D | 0.54 | 22,500 | 22,500 | |||||
| 2019-01-02 | 2018-12-31 | 4 | Angulo Gonzalez David | SCYX | Common stock | D | 0.4959 | 12,000 | 6 | 121,790 | ||||
| 2019-01-02 | 2018-12-31 | 4 | Taglietti Marco | SCYX | Common stock | D | 0.4600 | 25,000 | 12 | 455,000 | ||||
| 2018-10-03 | 2018-10-01 | 4 | Macdonald Guy | SCYX | Stock option (right to buy) | D | 1.22 | 0.7900 | 21,595 | 17 | 21,595 | |||
| 2018-09-10 | 2018-09-06 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1.2700 | 7,000 | 9 | 108,790 | ||||
| 2018-08-27 | 2018-08-23 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1.2900 | 25,000 | 32 | 429,000 | ||||
| 2018-07-03 | 2018-07-02 | 4 | Macdonald Guy | SCYX | Stock option (right to buy) | D | 1.69 | 1.1000 | 15,589 | 17 | 15,589 | |||
| 2018-07-03 | 2018-07-02 | 4 | McCourt Marion | SCYX | Stock option (right to buy) | D | 1.69 | 1.1000 | 9,217 | 10 | 9,217 | |||
| 2018-04-04 | 2018-04-02 | 4 | Macdonald Guy | SCYX | Stock option (right to buy) | D | 1.32 | 0.8600 | 19,959 | 17 | 19,959 | |||
| 2018-04-04 | 2018-04-02 | 4 | McCourt Marion | SCYX | Stock option (right to buy) | D | 1.32 | 0.8600 | 11,800 | 10 | 11,800 | |||
| 2018-04-02 | 2018-03-29 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1.3600 | 6,000 | 8 | 101,790 | ||||
| 2018-03-12 | 2018-03-08 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1.3900 | 7,000 | 10 | 95,790 | ||||
| 2018-03-12 | 2018-03-08 | 4 | Taglietti Marco | SCYX | Common Stock Warrant (right to buy) | D | 2.00 | 45,000 | 45,000 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Taglietti Marco | SCYX | Common Stock Warrant (right to buy) | D | 1.85 | 75,000 | 75,000 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1.6900 | 100,000 | 169 | 404,000 | ||||
| 2018-03-12 | 2018-03-08 | 4 | Sukenick Scott | SCYX | Common Stock Warrant (right to buy) | D | 2.00 | 1,331 | 1,331 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Sukenick Scott | SCYX | Common Stock Warrant (right to buy) | D | 1.85 | 2,219 | 2,219 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Sukenick Scott | SCYX | Common Stock | D | 1.6900 | 2,959 | 5 | 2,959 | ||||
| 2018-03-12 | 2018-03-08 | 4 | HASTINGS DAVID C | SCYX | Common Stock Warrant (right to buy) | D | 2.00 | 5,325 | 5,325 | |||||
| 2018-03-12 | 2018-03-08 | 4 | HASTINGS DAVID C | SCYX | Common Stock Warrant (right to buy) | D | 1.85 | 8,875 | 8,875 | |||||
| 2018-03-12 | 2018-03-08 | 4 | HASTINGS DAVID C | SCYX | Common Stock | D | 1.6900 | 11,834 | 20 | 31,834 | ||||
| 2018-03-12 | 2018-03-08 | 4 | Angulo Gonzalez David | SCYX | Common Stock Warrant (right to buy) | D | 2.00 | 6,655 | 6,655 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Angulo Gonzalez David | SCYX | Common Stock Warrant (right to buy) | D | 1.85 | 11,092 | 11,092 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1.6900 | 14,790 | 25 | 88,790 | ||||
| 2018-03-12 | 2018-03-08 | 4 | Francois Eric | SCYX | Common Stock Warrant (right to buy) | D | 2.00 | 2,662 | 2,662 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Francois Eric | SCYX | Common Stock Warrant (right to buy) | D | 1.85 | 4,437 | 4,437 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Francois Eric | SCYX | Common Stock | D | 1.6900 | 5,917 | 10 | 24,917 | ||||
| 2018-02-13 | 2018-02-09 | 4 | Sukenick Scott | SCYX | Stock option (right to buy) | D | 1.69 | 15,000 | 15,000 | |||||
| 2018-02-13 | 2018-02-09 | 4 | Taglietti Marco | SCYX | Stock option (right to buy) | D | 1.69 | 375,000 | 375,000 | |||||
| 2018-02-13 | 2018-02-09 | 4 | Francois Eric | SCYX | Stock option (right to buy) | D | 1.69 | 150,000 | 150,000 | |||||
| 2018-02-13 | 2018-02-09 | 4 | Angulo Gonzalez David | SCYX | Stock option (right to buy) | D | 1.69 | 200,000 | 200,000 | |||||
| 2018-01-04 | 2018-01-02 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 2.28 | 19,989 | 19,989 | |||||
| 2018-01-04 | 2018-01-02 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 2.28 | 19,989 | 19,989 | |||||
| 2018-01-04 | 2018-01-02 | 4 | HASTINGS DAVID C | SCYX | Stock Option (right to buy) | D | 2.28 | 19,989 | 19,989 | |||||
| 2018-01-04 | 2018-01-02 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 2.28 | 19,989 | 19,989 | |||||
| 2018-01-04 | 2018-01-02 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 2.28 | 1.4800 | 11,555 | 17 | 11,555 | |||
| 2018-01-04 | 2018-01-02 | 4 | Machado Patrick | SCYX | Stock Option (right to buy) | D | 2.28 | 19,989 | 19,989 | |||||
| 2018-01-04 | 2018-01-02 | 4 | McCourt Marion | SCYX | Stock Option (right to buy) | D | 2.28 | 19,989 | 19,989 | |||||
| 2018-01-04 | 2018-01-02 | 4 | McCourt Marion | SCYX | Stock Option (right to buy) | D | 2.28 | 1.4800 | 6,831 | 10 | 6,831 | |||
| 2017-11-17 | 2017-11-15 | 4 | Sukenick Scott | SCYX | Stock Option (right to buy) | D | 1.75 | 160,000 | 160,000 | |||||
| 2017-10-04 | 2017-10-02 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 2.46 | 1,807 | 1,807 | |||||
| 2017-10-04 | 2017-10-02 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 2.46 | 10,709 | 10,709 | |||||
| 2017-10-04 | 2017-10-02 | 4 | McCourt Marion | SCYX | Stock Option (right to buy) | D | 2.46 | 6,332 | 6,332 | |||||
| 2017-09-25 | 2017-09-22 | 4 | Taglietti Marco | SCYX | Common Stock | D | 2.2300 | 10,000 | 22 | 303,000 | ||||
| 2017-08-24 | 2017-08-23 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1.8500 | 4,993 | 9 | 292,000 | ||||
| 2017-08-24 | 2017-08-22 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1.6100 | 7 | 0 | 287,007 | ||||
| 2017-08-17 | 2017-08-15 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1.6100 | 10,000 | 16 | 287,000 | ||||
| 2017-08-14 | 2017-08-11 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1.5500 | 10,000 | 16 | 72,000 | ||||
| 2017-07-05 | 2017-07-03 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 1.83 | 2,430 | 2,430 | |||||
| 2017-07-05 | 2017-07-03 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 1.83 | 14,396 | 14,396 | |||||
| 2017-07-05 | 2017-07-03 | 4 | McCourt Marion | SCYX | Stock Option (right to buy) | D | 1.83 | 8,511 | 8,511 | |||||
| 2017-06-22 | 2017-06-21 | 4 | HASTINGS DAVID C | SCYX | Common Stock | D | 1.7500 | 20,000 | 35 | 20,000 | ||||
| 2017-05-15 | 2017-05-12 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1.7000 | 15,000 | 26 | 62,000 | ||||
| 2017-05-15 | 2017-05-12 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1.6900 | 25,000 | 42 | 277,000 | ||||
| 2017-04-04 | 2017-04-03 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 2.65 | 9,941 | 9,941 | |||||
| 2017-04-04 | 2017-04-03 | 4 | McCourt Marion | SCYX | Stock Option (right to buy) | D | 2.65 | 5,878 | 5,878 | |||||
| 2017-04-04 | 2017-04-03 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 2.65 | 1,678 | 1,678 | |||||
| 2017-02-02 | 2017-01-31 | 4 | Taglietti Marco | SCYX | Stock Option (right to buy) | D | 3.02 | 360,000 | 360,000 | |||||
| 2017-02-02 | 2017-01-31 | 4 | Angulo Gonzalez David | SCYX | Stock Option (right to buy) | D | 3.02 | 140,000 | 140,000 | |||||
| 2017-02-02 | 2017-01-31 | 4 | Francois Eric | SCYX | Stock Option (right to buy) | D | 3.02 | 100,000 | 100,000 | |||||
| 2017-01-27 | 2017-01-25 | 4 | McCourt Marion | SCYX | Stock Option (right to buy) | D | 3.15 | 34,144 | 34,144 | |||||
| 2017-01-27 | 2017-01-25 | 4 | McCourt Marion | SCYX | Stock Option (right to buy) | D | 3.15 | 4,274 | 4,274 | |||||
| 2017-01-05 | 2017-01-03 | 4 | HASTINGS DAVID C | SCYX | Stock Option (right to buy) | D | 3.40 | 14,499 | 14,499 | |||||
| 2017-01-05 | 2017-01-03 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 3.40 | 14,499 | 14,499 | |||||
| 2017-01-05 | 2017-01-03 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 3.40 | 14,499 | 14,499 | |||||
| 2017-01-05 | 2017-01-03 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 3.40 | 7,749 | 7,749 | |||||
| 2017-01-05 | 2017-01-03 | 4 | Machado Patrick | SCYX | Stock Option (right to buy) | D | 3.40 | 14,499 | 14,499 | |||||
| 2017-01-05 | 2017-01-03 | 4 | Langlois Patrick | SCYX | Stock Option (right to buy) | D | 3.40 | 14,499 | 14,499 | |||||
| 2017-01-05 | 2017-01-03 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 3.40 | 1,308 | 1,308 | |||||
| 2017-01-05 | 2017-01-03 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 3.40 | 14,499 | 14,499 | |||||
| 2016-12-22 | 2016-12-21 | 4 | Taglietti Marco | SCYX | Common Stock | D | 3.3000 | 25,000 | 82 | 251,000 | ||||
| 2016-12-19 | 2016-12-16 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 3.2500 | 4,000 | 13 | 46,000 | ||||
| 2016-10-04 | 2016-10-03 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 4.55 | 6,255 | 6,255 | |||||
| 2016-10-04 | 2016-10-03 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 4.55 | 977 | 977 | |||||
| 2016-09-16 | 2016-09-15 | 4 | Machado Patrick | SCYX | Common Stock | D | 2.9400 | 40,000 | 118 | 60,000 | ||||
| 2016-07-11 | 2016-07-01 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 2.19 | 12,996 | 12,996 | |||||
| 2016-07-11 | 2016-07-01 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 2.19 | 2,030 | 2,030 | |||||
| 2016-07-01 | 2016-06-30 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 2.2300 | 32,150 | 72 | 41,000 | ||||
| 2016-07-01 | 2016-06-29 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 2.1800 | 4,800 | 10 | 8,850 | ||||
| 2016-06-28 | 2016-06-24 | 4 | Macdonald Guy | SCYX | Common Stock Warrant (right to buy) | D | 3.00 | 0.0200 | 18,000 | 0 | 18,000 | |||
| 2016-06-28 | 2016-06-24 | 4 | Macdonald Guy | SCYX | Common Stock | D | 2.3900 | 40,000 | 96 | 40,000 | ||||
| 2016-06-28 | 2016-06-24 | 4 | Machado Patrick | SCYX | Common Stock Warrant (right to buy) | D | 3.00 | 0.0200 | 9,000 | 0 | 9,000 | |||
| 2016-06-28 | 2016-06-24 | 4 | Machado Patrick | SCYX | Common Stock | D | 2.3900 | 20,000 | 48 | 20,000 | ||||
| 2016-06-28 | 2016-06-24 | 4 | Taglietti Marco | SCYX | Common Stock Warrant (right to buy) | D | 3.00 | 0.0200 | 45,000 | 1 | 45,000 | |||
| 2016-06-28 | 2016-06-24 | 4 | Taglietti Marco | SCYX | Common Stock | D | 2.3900 | 100,000 | 239 | 225,000 | ||||
| 2016-06-28 | 2016-06-24 | 4 | Francois Eric | SCYX | Common Stock Warrant (right to buy) | D | 3.00 | 0.0200 | 6,750 | 0 | 6,750 | |||
| 2016-06-28 | 2016-06-24 | 4 | Francois Eric | SCYX | Common Stock | D | 2.3900 | 15,000 | 36 | 15,000 | ||||
| 2016-06-06 | 2016-06-02 | 4 | HASTINGS DAVID C | SCYX | Stock Option (right to buy) | D | 3.98 | 3.9800 | 8,800 | 35 | 8,800 | |||
| 2016-06-06 | 2016-06-02 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 3.98 | 3.9800 | 8,800 | 35 | 8,800 | |||
| 2016-06-06 | 2016-06-02 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 3.98 | 3.9800 | 8,800 | 35 | 8,800 | |||
| 2016-06-06 | 2016-06-02 | 4 | Machado Patrick | SCYX | Stock Option (right to buy) | D | 3.98 | 3.9800 | 8,800 | 35 | 8,800 | |||
| 2016-06-06 | 2016-06-02 | 4 | Langlois Patrick | SCYX | Stock Option (right to buy) | D | 3.98 | 3.9800 | 8,800 | 35 | 8,800 | |||
| 2016-06-06 | 2016-06-02 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 3.98 | 3.9800 | 8,800 | 35 | 8,800 | |||
| 2016-05-27 | 2016-05-25 | 4 | HANHAM ANN | SCYX | Common Stock | D | 3.6400 | 4,225 | 15 | 4,225 | ||||
| 2016-05-27 | 2016-05-25 | 4 | Taglietti Marco | SCYX | Common Stock | D | 3.2600 | 5,754 | 19 | 124,754 | ||||
| 2016-05-27 | 2016-05-25 | 4 | Taglietti Marco | SCYX | Common Stock | D | 3.2000 | 246 | 1 | 125,000 | ||||
| 2016-05-25 | 2016-05-24 | 4 | Taglietti Marco | SCYX | Common Stock | D | 3.3700 | 5,500 | 19 | 119,000 | ||||
| 2016-05-24 | 2016-05-23 | 4 | Taglietti Marco | SCYX | Common Stock | D | 3.1500 | 3,000 | 9 | 113,500 | ||||
| 2016-05-24 | 2016-05-20 | 4 | Taglietti Marco | SCYX | Common Stock | D | 3.1400 | 4,500 | 14 | 110,500 | ||||
| 2016-05-20 | 2016-05-19 | 4 | Taglietti Marco | SCYX | Common Stock | D | 3.0700 | 6,000 | 18 | 106,000 | ||||
| 2016-04-05 | 3/A | Angulo Gonzalez David | SCYX | Common Stock | D | 50 | ||||||||
| 2016-04-05 | 2016-04-01 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 4.05 | 7,027 | 7,027 | |||||
| 2016-04-05 | 2016-04-01 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 4.05 | 1,098 | 1,098 | |||||
| 2016-04-05 | 2016-04-01 | 4 | Taglietti Marco | SCYX | Stock Option (right to buy) | D | 4.05 | 185,000 | 185,000 | |||||
| 2016-04-05 | 2016-04-01 | 4 | Angulo Gonzalez David | SCYX | Stock Option (right to buy) | D | 4.05 | 70,000 | 70,000 | |||||
| 2016-04-05 | 2016-04-01 | 4 | Francois Eric | SCYX | Stock Option (right to buy) | D | 4.05 | 20,000 | 20,000 | |||||
| 2016-01-06 | 2016-01-04 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 6.10 | 4,666 | 4,666 | |||||
| 2016-01-06 | 2016-01-04 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 6.10 | 729 | 729 | |||||
| 2015-11-24 | 2015-11-24 | 4 | Taglietti Marco | SCYX | Common Stock | D | 6.8000 | 7,733 | 53 | 100,000 | ||||
| 2015-11-24 | 2015-11-23 | 4 | Taglietti Marco | SCYX | Common Stock | D | 6.7900 | 15,000 | 102 | 92,267 | ||||
| 2015-11-03 | 2015-11-02 | 4 | Francois Eric | SCYX | Stock Option (right to buy) | D | 6.53 | 100,000 | 100,000 | |||||
| 2015-10-05 | 2015-10-01 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 6.64 | 670 | 670 | |||||
| 2015-10-05 | 2015-10-01 | 4 | Langlois Patrick | SCYX | Stock Option (right to buy) | D | 6.64 | 1,607 | 1,607 | |||||
| 2015-10-05 | 2015-10-01 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 6.64 | 4,286 | 4,286 | |||||
| 2015-09-28 | 2015-09-24 | 4 | Machado Patrick | SCYX | Stock Option (right to buy) | D | 6.89 | 11,700 | 11,700 | |||||
| 2015-09-28 | 2015-09-24 | 4 | HASTINGS DAVID C | SCYX | Stock Option (right to buy) | D | 6.89 | 11,700 | 11,700 | |||||
| 2015-09-18 | 2015-09-15 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 7.0000 | 3,000 | 21 | 3,000 | ||||
| 2015-09-02 | 2015-08-31 | 4 | Taglietti Marco | SCYX | Common Stock | D | 7.8200 | 25,000 | 196 | 77,267 | ||||
| 2015-08-31 | 2015-08-28 | 4 | Taglietti Marco | SCYX | Common Stock | D | 7.1500 | 400 | 3 | 52,267 | ||||
| 2015-08-31 | 2015-08-27 | 4 | Taglietti Marco | SCYX | Common Stock | D | 7.0700 | 1,867 | 13 | 51,867 | ||||
| 2015-08-27 | 2015-08-26 | 4 | Taglietti Marco | SCYX | Common Stock | D | 6.9800 | 25,000 | 174 | 50,000 | ||||
| 2015-08-27 | 2015-08-25 | 4 | Taglietti Marco | SCYX | Common Stock | D | 7.1500 | 20,000 | 143 | 25,000 | ||||
| 2015-08-27 | 2015-08-25 | 4 | Taglietti Marco | SCYX | Common Stock | D | 7.1600 | 5,000 | 36 | 5,000 | ||||
| 2015-07-31 | 3 | Woodall Jonathan Sears | SCYX | Common Stock | D | 1,000 | ||||||||
| 2015-07-31 | 3 | Woodall Jonathan Sears | SCYX | Common Stock | D | 1,000 | ||||||||
| 2015-07-24 | 2015-07-22 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 8.64 | 8,800 | 8,800 | |||||
| 2015-07-06 | 2015-07-01 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 8.86 | 502 | 502 | |||||
| 2015-07-06 | 2015-07-01 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 8.86 | 2,974 | 2,974 | |||||
| 2015-07-06 | 2015-07-01 | 4 | Langlois Patrick | SCYX | Stock Option (right to buy) | D | 8.86 | 1,465 | 1,465 | |||||
| 2015-06-05 | 2015-06-04 | 4 | PENHOET EDWARD | SCYX | Stock Option (right to buy) | D | 8.65 | 8,800 | 8,800 | |||||
| 2015-06-05 | 2015-06-04 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 8.65 | 8,800 | 8,800 | |||||
| 2015-06-05 | 2015-06-04 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 8.65 | 8,800 | 8,800 | |||||
| 2015-06-05 | 2015-06-04 | 4 | Langlois Patrick | SCYX | Stock Option (right to buy) | D | 8.65 | 8,800 | 8,800 | |||||
| 2015-06-05 | 2015-06-04 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 8.65 | 8,800 | 8,800 | |||||
| 2015-06-05 | 2015-06-04 | 4 | Angulo Gonzalez David | SCYX | Stock Option (right to buy) | D | 8.65 | 125,000 | 125,000 | |||||
| 2015-04-03 | 2015-04-01 | 4 | KIRBY PAMELA J | SCYX | Stock Option (right to buy) | D | 8.76 | 1,976 | 1,976 | |||||
| 2015-04-03 | 2015-04-01 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 8.76 | 1,976 | 1,976 | |||||
| 2015-04-03 | 2015-04-01 | 4 | Langlois Patrick | SCYX | Stock Option (right to buy) | D | 8.76 | 1,207 | 1,207 | |||||
| 2015-04-03 | 2015-04-01 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 8.76 | 554 | 544 | |||||
| 2015-04-03 | 2015-04-01 | 4 | Taglietti Marco | SCYX | Stock Option (right to buy) | D | 8.76 | 330,000 | 330,000 | |||||
| 2015-04-03 | 2015-04-01 | 4 | Nothias Jean-Yves | SCYX | Stock Option (right to buy) | D | 8.76 | 1,690 | 1,690 | |||||
| 2015-04-03 | 2015-04-01 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 8.76 | 50,000 | 50,000 | |||||
| 2015-04-03 | 2015-04-01 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 8.76 | 9,541 | 9,541 | |||||
| 2015-02-27 | 2015-02-25 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 10.00 | 486 | 486 | |||||
| 2015-02-27 | 2015-02-25 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 10.00 | 7,830 | 7,830 | |||||
| 2015-01-06 | 2015-01-02 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 9.96 | 2,047 | 2,047 | |||||
| 2015-01-06 | 2015-01-02 | 4 | Langlois Patrick | SCYX | Stock Option (right to buy) | D | 9.96 | 869 | 869 | |||||
| 2015-01-06 | 2015-01-02 | 4 | KIRBY PAMELA J | SCYX | Stock Option (right to buy) | D | 9.96 | 1,738 | 1,738 | |||||
| 2015-01-06 | 2015-01-02 | 4 | Taglietti Marco | SCYX | Stock Option (right to buy) | D | 9.96 | 1,660 | 1,660 | |||||
| 2015-01-06 | 2015-01-02 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 9.96 | 1,738 | 1,738 | |||||
| 2015-01-06 | 2015-01-02 | 4 | Nothias Jean-Yves | SCYX | Stock Option (right to buy) | D | 9.96 | 1,274 | 1,274 | |||||
| 2014-12-04 | 2014-12-02 | 4 | Taglietti Marco | SCYX | Stock Option (right to buy) | D | 10.81 | 1,530 | 1,530 | |||||
| 2014-12-04 | 2014-12-02 | 4 | Taglietti Marco | SCYX | Stock Option (right to buy) | D | 10.81 | 7,830 | 7,830 | |||||
| 2014-12-04 | 2014-12-02 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 10.81 | 7,830 | 7,830 | |||||
| 2014-10-02 | 2014-10-01 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 7.70 | 2,048 | 2,048 | |||||
| 2014-10-02 | 2014-10-01 | 4 | Nothias Jean-Yves | SCYX | Stock Option (right to buy) | D | 7.70 | 1,648 | 1,648 | |||||
| 2014-10-02 | 2014-07-01 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 8.03 | 1,964 | 1,964 | |||||
| 2014-10-02 | 2014-07-01 | 4 | Nothias Jean-Yves | SCYX | Stock Option (right to buy) | D | 8.03 | 1,581 | 1,581 | |||||
| 2014-10-02 | 2014-10-01 | 4 | KIRBY PAMELA J | SCYX | Stock Option (right to buy) | D | 7.70 | 2,248 | 2,248 | |||||
| 2014-10-02 | 2014-07-01 | 4 | KIRBY PAMELA J | SCYX | Stock Option (right to buy) | D | 8.03 | 2,155 | 2,155 | |||||
| 2014-06-20 | 2014-06-18 | 4 | PRUETTE EILEEN | SCYX | Stock Option (right to buy) | D | 9.64 | 25,230 | 25,230 | |||||
| 2014-06-20 | 2014-06-18 | 4 | PRUETTE EILEEN | SCYX | Stock Option (right to buy) | D | 24.48 | -9,803 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | PRUETTE EILEEN | SCYX | Stock Option (right to buy) | D | 9.64 | 9,803 | 9,803 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9.64 | 187,052 | 187,052 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 30.60 | -1,960 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9.64 | 1,960 | 1,960 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 25.91 | -2,941 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 20.40 | -2,941 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9.64 | 2,941 | 2,941 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9.64 | 2,941 | 2,941 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 25.50 | -3,676 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 20.40 | -3,676 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9.64 | 3,676 | 3,676 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9.64 | 3,676 | 3,676 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 20.40 | -931 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9.64 | 931 | 931 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 20.40 | -7,352 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 20.40 | -7,352 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9.64 | 7,352 | 7,352 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9.64 | 7,352 | 7,352 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9.64 | 57,420 | 57,420 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 30.60 | -833 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9.64 | 833 | 833 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 25.91 | -1,470 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9.64 | 1,470 | 1,470 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 25.50 | -1,225 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 20.40 | -1,225 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9.64 | 1,225 | 1,225 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9.64 | 1,225 | 1,225 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 20.40 | -808 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9.64 | 808 | 808 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 20.40 | -490 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9.64 | 490 | 490 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 20.40 | -934 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9.64 | 934 | 934 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 20.40 | -960 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9.64 | 960 | 960 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Sable Carole | SCYX | Stock Option (right to buy) | D | 9.64 | 26,970 | 26,970 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Sable Carole | SCYX | Stock Option (right to buy) | D | 10.00 | -46,636 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Sable Carole | SCYX | Stock Option (right to buy) | D | 9.64 | 46,636 | 46,636 | |||||
| 2014-06-13 | 2014-06-11 | 4 | KIRBY PAMELA J | SCYX | Stock Option (right to buy) | D | 8.73 | 1,321 | 1,321 | |||||
| 2014-06-13 | 2014-06-11 | 4 | KIRBY PAMELA J | SCYX | Stock Option (right to buy) | D | 8.73 | 5,220 | 5,220 | |||||
| 2014-06-13 | 2014-06-11 | 4 | PENHOET EDWARD | SCYX | Stock Option (right to buy) | D | 8.73 | 3,480 | 3,480 | |||||
| 2014-06-13 | 2014-06-11 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 8.73 | 1,204 | 1,204 | |||||
| 2014-06-13 | 2014-06-11 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 8.73 | 3,480 | 3,480 | |||||
| 2014-06-13 | 2014-06-11 | 4 | Langlois Patrick | SCYX | Stock Option (right to buy) | D | 8.73 | 3,480 | 3,480 | |||||
| 2014-06-13 | 2014-06-11 | 4 | Nothias Jean-Yves | SCYX | Stock Option (right to buy) | D | 8.73 | 969 | 969 | |||||
| 2014-06-13 | 2014-06-11 | 4 | Nothias Jean-Yves | SCYX | Stock Option (right to buy) | D | 8.73 | 3,480 | 3,480 | |||||
| 2014-06-13 | 2014-06-11 | 4 | Chaoui Mounia | SCYX | Stock Option (right to buy) | D | 8.73 | 3,480 | 3,480 | |||||
| 2014-06-13 | 2014-06-11 | 4 | Arthaud Laurent | SCYX | Stock Option (right to buy) | D | 8.73 | 3,480 | 3,480 | |||||
| 2014-05-09 | 3 | Sanofi Via wholly owned subsidiary Merial Limited | SCYX | Shares | I | 1,805,363 | ||||||||
| 2014-05-09 | 3 | Sanofi Via wholly owned subsidiary Aventisub Inc. | SCYX | Shares | I | 3,177,057 | ||||||||
| 2014-05-09 | 3 | Sanofi Via wholly owned subsidiary Aventis Agriculture | SCYX | Shares | I | 1,725,808 | ||||||||
| 2014-05-09 | 3 | Sanofi Via wholly owned subsidiary Aventisub Inc. | SCYX | Shares | I | 3,177,057 | ||||||||
| 2014-05-09 | 3 | Sanofi Via wholly owned subsidiary Merial Limited | SCYX | Shares | I | 1,805,363 | ||||||||
| 2014-05-09 | 3 | Sanofi Via wholly owned subsidiary Aventis Agriculture | SCYX | Shares | I | 1,725,808 | ||||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Series D-2 Preferred Stock | D | -341,456 | 0 | ||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Series D-1 Preferred Stock | D | -955,215 | 0 | ||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Series C Preferred Stock | D | -342,726 | 0 | ||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Series B Preferred Stock | D | -188,679 | 0 | ||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock Warrant (right to buy) | D | 0.20 | -3,501 | 0 | |||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock Warrant (right to buy) | D | 0.20 | -5,251 | 0 | |||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock Warrant (right to buy) | D | 0.20 | -5,251 | 0 | |||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock | D | 10.0000 | 10,000 | 100 | 237,598 | ||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock | D | 16,738 | 227,598 | ||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock | D | 46,824 | 210,860 | ||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock | D | 96,921 | 164,036 | ||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock | D | 53,112 | 67,115 | ||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock | D | 0.2000 | 3,501 | 1 | 14,003 | ||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock | D | 0.2000 | 5,251 | 1 | 10,502 | ||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock | D | 0.2000 | 5,251 | 1 | 10,502 | ||||
| 2014-05-08 | 3/A | Arthaud Laurent By wife | SCYX | Common Stock | I | 3,738 | ||||||||
| 2014-05-08 | 3/A | Arthaud Laurent | SCYX | Common Stock | D | 735 | ||||||||
| 2014-05-08 | 2014-05-07 | 4 | KIRBY PAMELA J | SCYX | Series D-2 Preferred Stock | D | -260,000 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | KIRBY PAMELA J | SCYX | Common Stock Warrant (right to buy) | D | 0.20 | -12,745 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | KIRBY PAMELA J | SCYX | Common Stock | D | 12,745 | 25,590 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | KIRBY PAMELA J | SCYX | Common Stock | D | 0.2000 | 12,745 | 3 | 12,745 | ||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Series D-2 Preferred Stock | I | -53,915 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Series D-1 Preferred Stock | I | -37,702 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Series C Preferred Stock | I | -20,975 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock Warrant (right to buy) | I | 0.20 | -3,033 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock Warrant (right to buy) | I | 0.20 | -174 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock Warrant (right to buy) | I | 0.20 | -174 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Series D-2 Preferred Stock | D | -1,417,315 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Series D-1 Preferred Stock | D | -1,024,876 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Series C Preferred Stock | D | -570,159 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock Warrant (right to buy) | D | 0.20 | -82,454 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock Warrant (right to buy) | D | 0.20 | -4,551 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock Warrant (right to buy) | D | 0.20 | -4,551 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock | I | 10.0000 | 31,934 | 319 | 45,736 | ||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock | I | 2,642 | 13,802 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock | I | 1,848 | 11,160 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock | I | 5,931 | 9,312 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock | I | 0.2000 | 3,033 | 1 | 3,381 | ||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock | I | 0.2000 | 174 | 0 | 348 | ||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock | I | 0.2000 | 174 | 0 | 348 | ||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock | D | 10.0000 | 868,066 | 8,681 | 1,240,575 | ||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock | D | 69,476 | 372,509 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock | D | 50,239 | 303,033 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock | D | 161,238 | 252,794 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock | D | 0.2000 | 82,454 | 16 | 91,556 | ||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock | D | 0.2000 | 4,551 | 1 | 9,102 | ||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock | D | 0.2000 | 4,551 | 1 | 9,102 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Langlois Patrick By DFC Langlois | SCYX | Series D-2 Preferred Stock | I | -107,142 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Langlois Patrick By DFC Langlois | SCYX | Common Stock Warrant (right to buy) | I | 0.20 | -5,251 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Langlois Patrick By DFC Langlois | SCYX | Common Stock | I | 5,252 | 10,503 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Langlois Patrick By DFC Langlois | SCYX | Common Stock | I | 0.2000 | 5,251 | 1 | 26,785 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Series D-2 Preferred Stock | I | -623,880 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Series D-1 Preferred Stock | I | -863,672 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Series C Preferred Stock | I | -313,996 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Series B Preferred Stock | I | -166,482 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock Warrant (right to buy) | I | 0.20 | -25,998 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock Warrant (right to buy) | I | 0.20 | -5,251 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock Warrant (right to buy) | I | 0.20 | -5,251 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock | I | 10.0000 | 50,000 | 500 | 295,077 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock | I | 30,582 | 245,077 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock | I | 42,336 | 214,495 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock | I | 88,796 | 172,159 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock | I | 46,863 | 83,363 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock | I | 0.2000 | 25,998 | 5 | 36,500 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock | I | 0.2000 | 5,251 | 1 | 10,502 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock | I | 0.2000 | 5,251 | 1 | 10,502 | ||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Series D-2 Preferred Stock | D | -623,880 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Series D-1 Preferred Stock | D | -863,672 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Series C Preferred Stock | D | -313,996 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Series B Preferred Stock | D | -166,482 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock Warrant (right to buy) | D | 0.20 | -25,998 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock Warrant (right to buy) | D | 0.20 | -5,251 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock Warrant (right to buy) | D | 0.20 | -5,251 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock | D | 10.0000 | 50,000 | 500 | 295,077 | ||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock | D | 30,582 | 245,077 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock | D | 42,336 | 214,495 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock | D | 88,796 | 172,159 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock | D | 46,863 | 83,363 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock | D | 0.2000 | 25,998 | 5 | 36,500 | ||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock | D | 0.2000 | 5,251 | 1 | 10,502 | ||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock | D | 0.2000 | 5,251 | 1 | 10,502 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Ribeill Yves J | SCYX | Series D-2 Preferred Stock | D | -12,142 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ribeill Yves J | SCYX | Common Stock Warrant (right to buy) | D | 0.20 | -595 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Ribeill Yves J | SCYX | Common Stock | D | 595 | 1,190 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ribeill Yves J | SCYX | Common Stock | D | 0.2000 | 595 | 0 | 595 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Series D-2 Preferred Stock | I | -1,665 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Series D-1 Preferred Stock | I | -8,127 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Common Stock Warrant (right to buy) | I | 0.20 | -222 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Common Stock Warrant (right to buy) | I | 0.20 | -34 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Common Stock Warrant (right to buy) | I | 0.20 | -34 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Common Stock | I | 81 | 4,507 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Common Stock | I | 398 | 4,426 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Common Stock | I | 0.2000 | 222 | 0 | 4,028 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Common Stock | I | 0.2000 | 34 | 0 | 3,806 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Common Stock | I | 0.2000 | 34 | 0 | 3,806 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Series D-2 Preferred Stock | D | -3,010,807 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Series D-1 Preferred Stock | D | -809,584 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Series C Preferred Stock | D | -340,509 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Series B Preferred Stock | D | -109,879 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock Warrant (right to buy) | D | 0.20 | -43,704 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock Warrant (right to buy) | D | 0.20 | -14,005 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock Warrant (right to buy) | D | 0.20 | -14,005 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock | D | 10.0000 | 28,000 | 280 | 414,211 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock | D | 147,588 | 386,211 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock | D | 39,685 | 238,623 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock | D | 96,294 | 198,938 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock | D | 30,930 | 102,644 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock | D | 0.2000 | 43,704 | 9 | 71,714 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock | D | 0.2000 | 14,005 | 3 | 28,010 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock | D | 0.2000 | 14,005 | 3 | 28,010 | ||||
| 2014-05-02 | 3 | Garrett Michael C | SCYX | Common Stock | D | 6,216 | ||||||||
| 2014-05-02 | 3 | Garrett Michael C | SCYX | Common Stock | D | 6,216 | ||||||||
| 2014-05-02 | 3 | Ribeill Yves J | SCYX | Common Stock | D | 33,950 | ||||||||
| 2014-05-02 | 3 | Ribeill Yves J | SCYX | Common Stock | D | 33,950 | ||||||||
| 2014-05-02 | 3 | Arthaud Laurent | SCYX | Common Stock | D | 1,470 | ||||||||
| 2014-05-02 | 3 | Arthaud Laurent | SCYX | Common Stock | D | 1,470 | ||||||||
| 2014-05-02 | 3 | Osborne, Jr. Charles F | SCYX | Common Stock | D | 17,900 | ||||||||
| 2014-05-02 | 3 | Osborne, Jr. Charles F | SCYX | Common Stock | D | 17,900 |
P
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매입
S
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매각
A
자사로부터 유가증권(옵션 등)을 보조, 지급 또는 기타 취득
C
파생상품 전환
D
자사에게 유가증권을 매각 또는 양도
F
기업으로부터 인도 받은 유가증권의 일부를 사용한 행사 가격 또는 조세 채무의 지급
G
내부자에 의한 또는 내부자에게 증권 증여
K
지분스왑 및 유사 위험 회피거래
M
자사로부터 인도 받은 파생증권(옵션 등)의 행사 또는 전환
V
보고서 양식 4에 자진 신고된 거래
J
기타 (거래 내용을 설명하는 각주와 동반)
